Octreotide 20mg powder and solvent for suspension for injection vials
| ID | 36029711000001102 |
|---|---|
| Date | 29 Oct 2018 |
| Previous ID | 327350005 |
| Therapeutic Moiety | Octreotide |
| Name | Octreotide 20mg powder and solvent for suspension for injection vials |
| Abbreviated name | Octreotide 20mg inj vials |
| Preferred name basis | rINN - Recommended International Non-proprietary |
| Date of name applicability | 9 Jun 2004 |
| Previous name | Octreotide 20mg injection vials and diluent |
| Basis of previous name | rINN - Recommended International Non-proprietary |
| Reason for name change | Other |
| Prescribing status | Valid as a prescribable product |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | vial |
| Unit dose unit of measure | vial |
| Ingredients | Octreotide acetate |
| Form & Route | suspensioninjection.intramuscular-deep |
| Drug formulations | Powder and solvent for suspension for injection |
| Drug route | Intramuscular |
| Control drug | No Controlled Drug Status |